Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.06.2023 | Case report

Sorafenib

Various toxicities: 5 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Morin S, et al. Real-world experience of sorafenib maintenance after allogeneic hematopoietic stem cell transplantation for FLT3-ITD AML reveals high rates of toxicity-related treatment interruption. Frontiers in Oncology 13: Jan 2023. Available from: URL: http://doi.org/10.3389/fonc.2023.1095870 Morin S, et al. Real-world experience of sorafenib maintenance after allogeneic hematopoietic stem cell transplantation for FLT3-ITD AML reveals high rates of toxicity-related treatment interruption. Frontiers in Oncology 13: Jan 2023. Available from: URL: http://​doi.​org/​10.​3389/​fonc.​2023.​1095870
Metadaten
Titel
Sorafenib
Various toxicities: 5 case reports
Publikationsdatum
01.06.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-41632-4

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Antineoplastics

Case report

Multiple drugs

Case report

Cefadroxil

Case report

Multiple drugs

Case report

Risperidone